Navigation Links
Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
Date:6/23/2008

IRVINE, Calif., June 23 /PRNewswire/ -- Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announces that Mr. Bruce Palsulich has joined the company as Chief Innovation & Strategy Officer, reporting directly to the CEO. In this role, he will oversee Relsys' future product development and direction, and drive corporate strategic initiatives.

Mr. Palsulich is one of Relsys' original employees, having been with the company since inception. He was formerly Vice President of Product Development at Relsys, departing in 2004 to pursue personal entrepreneurial initiatives. At the time, he was responsible for customer requirements, product direction and business development. Mr. Palsulich is also the original developer of the Argus Safety(TM) suite. He brings with him extensive knowledge and understanding of the pharmaceutical industry, particularly in risk management.

Mr. Dave Bajaj, President & CEO of Relsys, commented, "We welcome Bruce back to the Relsys organization. His return has been very well received by clients who have worked with him in the past. His broad, in-depth understanding of and exposure to global pharmacovigilance business practices will provide the backbone of our future product direction." Mr. Palsulich added, "Relsys has demonstrated unparalleled growth, rapidly gaining the largest user base of any drug safety system in the world. I look forward to working closely with this large client pool to continue to expand Relsys' risk management leadership."

About Relsys International

Relsys International provides the industry-leading Argus suite, a complete systems solution for drug safety, pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's best selling drug safety and adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit http://www.relsys.net, or call +1 949-453-1715.


'/>"/>
SOURCE Relsys International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California
2. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
3. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
4. Statement by Bruce Bodaken on Senate Health Committee Action
5. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
6. A product for the detection and characterization of brucellosis launched at University of Navarra
7. Richard Greco Joins Mediware Board
8. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
9. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
10. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
11. Nick Childs Joins Grey New York as Director of Content Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Starting today, households ... mail from USA Medical Prescription Assistance Program. They are customized to reflect the ... package will include a ready-to-use, state-themed card and, in the near future, material ...
(Date:4/28/2016)... ... April 28, 2016 , ... The Aging in Motion Coalition ... an ICD-10-CM code for sarcopenia, giving it recognition for separate reporting and data collection. ... 1, 2016. , Sarcopenia is defined as a combination of low muscle mass and ...
(Date:4/28/2016)... ... April 28, 2016 , ... North Hollywood dentist , Dr. Hamid ... is essential when it comes to dental accidents or critical dental problems. These issues ... losing a tooth. Toothaches, knocked-out teeth, chipped teeth, and many other issues can lead ...
(Date:4/28/2016)... (PRWEB) , ... April 28, ... ... an invitation to those affected by a health insurance co-operative bankruptcy to ... proprietary process, individuals can receive over 1,500 FDA-approved prescription medications from over ...
(Date:4/28/2016)... , ... April 28, 2016 , ... For many, a diet is only as good ... if it does not look good. In addition, an individual cannot deny the importance of ... , The team, therefore, has worked to create a product range that could entice people ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... April 27, 2016 Shire plc (LSE: ... Poulton , Chief Financial Officer, will present at the Deutsche ... MA on Wednesday, May 04, 2016, 10:00 am ... be available on the Presentations and Webcasts section of Shire,s ... the webcast will be available on this same website for ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/27/2016)... FRANCISCO , April 27, 2016 ... expected to reach USD 2.06 billion by 2022, ... Research, Inc. Increasing consumer awareness towards a healthy ... the next seven years.      (Logo: ... diet intake coupled with rising health treatment expenditure ...
Breaking Medicine Technology: